This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

FDA approves Teva’s first generic GLP-1 drug for weight loss, based on Novo Nordisk’s Saxenda. Saxenda recorded $165 million in annual sales as of June 2025. See the trading strategy with a perfect ...